Research > ETFs > ETF / ETP Commentary > 

International Equities ETF XIDV Beating Benchmark, Category

Investors are looking to balance concentration risk and returns amid brewing anxiety about U.S. stocks. While the push and pull of Middle East diplomacy continues, A.I. concerns remain as many investors are heavily invested in just a few AI hyperscalers. International equities offer diversification and performance in funds like the Franklin International Dividend Booster Index ETF (XIDV ), which is beating its category average and benchmark.Key Takeaways: With just a handful of stocks driving about 40% of S&P 500 movement, diversification has a big role to play. The international equity ETF space can provide just that via funds like XIDV, up 18.55% YTD. The strategy has also done well this month, beating its ETF Database category average over the last month. XIDV charges a 19 basis point (bps) fee to track the VettaFi New Frontier International Dividend Select Index. The fund includes large and midcap developed markets names. XIDV looks to offer a high dividend yield balanced against the volatility in the broad international equity space. The index looks to limit weights for individual stocks to 2.5% and sectors and countries limited to 30%. Per ETF Database data, the fund is heavily allocated to Europe, led by France, Italy, and the U.K. Japan, Canada, and Australia take up some of the largest weights outside of Europe.International Equities ETF XIDV: What to WatchThe international equities ETF has taken that approach and produced some strong returns. XIDV has returned 7% over the last month according to ETF Database data. That has outperformed the ETF Database Global Equities category average in that time. The average has returned just 0.2% in the last month. Meanwhile, XIDV has also outperformed its benchmark, of late. Per Franklin Templeton data, the ETF’s index, the VettaFi Developed World ex United States Index has returned 11.5% YTD. XIDV has, by contrast, returned 18.55% YTD according to ETF Database data. Together, that paints a picture of a solid international equities ETF offering. The fund’s 19 bps fee is on the lower side, making it an intriguing satellite ETF offering. It’s also provided a 15.7% NAV distribution rate as of July 31st. See more: How Autism Research ETF ASD Can Deliver for Your Portfolio Looking ahead, its diversification across Europe and Asia can appeal, diversifying within the ex-U.S. space. Furthermore, its combination of energy minerals and more defensive segments like finance can diversify it even more, boosting its overall case. For those looking at the space, XIDV can appeal. For more news, information, and analysis, visit the Thematic Investing Content Hub. VettaFi LLC (“VettaFi”) is the index provider for XIDV for which it receives an index licensing fee. However, XIDV is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of XIDV.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.